ArticleCancer chemotherapy and pharmacology2021

Phase 1 study of alisertib (MLN8237) and weekly irinotecan in adults with advanced solid tumors.

Thomas J Semrad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.